Clinical vs haemodynamic response to drugs in portal hypertension
Authors:
- David PatchDPDavid Patch
- Lynda GreensladeLGLynda Greenslade
- Jason ChinJCJason Chin
- Neil McIntyreNMNeil McIntyre
- Andrew K. BurroughsABAndrew K. Burroughs
- 1 June 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 28 (6) , 1015-1019
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosisThe Lancet, 1996
- Nadolol plus Isosorbide Mononitrate Compared with Sclerotherapy for the Prevention of Variceal RebleedingNew England Journal of Medicine, 1996
- Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosisThe Lancet, 1995
- Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failureJournal of Hepatology, 1994
- Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhageGastroenterology, 1990
- Enhancement of Portal Pressure Reduction by the Association of Isosorbide–5–Mononitrate to Propranolol Administration in Patients With CirrhosisHepatology, 1990
- Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosisJournal of Hepatology, 1989
- Cirrhotics with variceal hemorrhage: The importance of the time interval between admission and the start of analysis for survival and rebleeding ratesHepatology, 1989
- Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranololJournal of Hepatology, 1987
- Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in CirrhosisHepatology, 1984